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10 The Journal of Thoracic and Cardiobjective: Reactive free radical species are thought to be involved in postoperative
eurologic dysfunction after antegrade selective cerebral perfusion in brains with
ld infarction. We assessed the brain protective effect of prophylactically adminis-
ered edaravone, a free radical scavenger, for antegrade selective cerebral perfusion
n brains with or without old infarction in a canine model.
ethods: A canine model of old cerebral infarction was created by injecting
ylindric silicone embolus into the middle cerebral artery. Animals showing obvious
eurologic deficits and surviving 4 weeks or longer were included in the model.
eep hypothermia with antegrade selective cerebral perfusion was performed in
oth intact (non-edaravone, group A; edaravone-treated, group B) and infarcted
nimals (non-edaravone, group C; edaravone-treated, group D). Serum concentra-
ions of malondialdehyde, hexanoyl-lysine, glutamate, and venous-arterial lactate
ifference were measured, and central conduction time and amplitude of somato-
ensory evoked potentials were assessed during the operation.
esults: Compared with the intact groups, serum concentrations of malondialdehyde
nd hexanoyl-lysine in group C significantly increased at the end of antegrade
elective cerebral perfusion, whereas that of glutamate did so in the rewarming
hase. Increases in all these biochemical parameters were suppressed in group D. In
roup C, the venous-arterial lactate difference was significantly greater in the
ewarming phase at 28°C compared with intact groups. A significant prolongation
f postoperative central conduction time and decrease in neuronal activity were
etected in group C, both of which recovered in group D.
onclusion: Prophylactic administration of edaravone exerted a significant protec-
ive effect against postoperative neurologic dysfunction after antegrade selective
erebral perfusion in a canine model with old cerebral infarction.
ostoperative neurologic dysfunction is one of the most serious complications
after aortic arch operation. The incidence of this complication has decreased
in recent times because of improvements in operative techniques and cerebral
rotection methods.1 Antegrade selective cerebral perfusion (ASCP) has been found
o be the safest method of brain protection during aortic arch surgery with respect
o energy metabolism and time limitation.2,3 Clinical practice has indicated that
SCP can reduce cerebral injury during aortic arch operation more effectively
ompared with other methods for cerebral protection, including deep hypothermic
irculatory arrest with or without retrograde cerebral perfusion.4 Although our total
rch replacement assisted with ASCP has resulted in a lower rate of mortality and
orbidity,5 a multivariable analysis of 220 patients revealed that a history of
vascular Surgery ● March 2007
cp
m
l
r
r
a
i
s
u
S
d
J
w
a
s
u
e
c
A
n
e
b
M
T
o
c
U
o
l
U
C
O
s
t
i
l
t
a
l
d
s
a
s
s
i
A
A
b
1
a
c
v
a
b
C
A
d
c
t
c
k
s
t
b
M
S
F
e
c
s
r
p
u
2
w
s
c
n
l
n
n
c
w
E
T
4
i
e
g
m
8
A
A
t
Suzuki et al Cardiopulmonary Support and Physiology
CS
Perebral infarction should be regarded as an independent
redictor of postoperative neurologic dysfunction.6
Our previous canine studies showed that ASCP in ani-
als with old cerebral infarction induced ischemic neuro-
ogic damage and that it increased the production of free
adicals, suggesting oxidative damage in the peri-infarct
egion of the brain.7,8 Many previous reports described
ccelerated production of free radicals in acute cerebral
nfarction resulting in neurologic damage, and free radical
cavenger has already been found to be effective in atten-
ating such neurologic damage in clinical situations.9,10
imilarly, a recent experimental study from our laboratory
ocumented that edaravone (Mitsubishi Pharma Co, Tokyo,
apan), a commercially available free radical scavenger,
as effective in attenuating acute ischemic neurologic dam-
ge in the rabbit spinal cord.11 However, the exact relation-
hip between free radicals and old cerebral infarction is
nknown. A pharmacologic agent with a similar protective
ffect on brains with old cerebral infarct can be of great
linical relevance during an aortic arch operation with
SCP. Therefore, in the present study, we assessed the
europrotective effect of prophylactically administered
daravone for ASCP in brains with or without old cere-
ral infarction in a canine model.
aterials and Methods
he study was approved by the Animal Care and Use Committee
f Hamamatsu University School of Medicine. All animals re-
eived human care in compliance with the “Guide for the Care and
se of Laboratory Animals,” published by the National Institutes
f Hearth (NIH publication 85-23, revised 1985), and the “Guide-
ines for Animal Experimentation,” formulated by Hamamatsu
niversity School of Medicine (published 1987, revised 1991).
erebral Infarct Model
ur technique of creating a cerebral infarct model has been de-
cribed.7 In short, the left common carotid artery with its bifurca-
ion was surgically exposed, and a cylindric silicone embolus was
njected into the left internal carotid artery. Nonvisualization of the
eft middle cerebral artery in the subsequent angiogram suggested
hat the embolus was located in the proximal left middle cerebral
rtery. Twelve hours later, the dogs were evaluated with a neuro-
ogic scoring system consisting of 5 grades (score 0: no neurologic
eficit; score 1: walks with limp or circles to the side of lesion;
Abbreviations and Acronyms
ASCP  antegrade selective cerebral perfusion
CCT  central conduction time
CPB  cardiopulmonary bypass
HEL  hexanoyl-lysine
MDA malondialdehyde
VALD venous-arterial lactate differencecore 2: walks poorly and stands but cannot support the body with d
The Journal of Thoracic left limb held off the ground; score 3: cannot stand without
upport; and score 4: dead).12 Only the dogs with neurologic
cores of 2 and 3, and surviving 4 weeks or longer were included
n the cerebral infarct model.
nimal Preparation
fter general anesthesia with an intravenous injection of pento-
arbital sodium (30 mg/kg), mechanical ventilation was started. A
9-gauge detaining needle was inserted into the right brachial
rtery for blood sampling and blood pressure monitoring. A 4F
atheter was placed into the right maxillary vein for sampling of
enous blood for blood gas analysis and lactate measurement. An
dditional dose of pentobarbital sodium (15 mg/kg) was given
efore the beginning of rewarming.
ardiopulmonary Bypass
fter median sternotomy and full heparinization (300 U/kg), car-
iopulmonary bypass (CPB) was instituted by inserting the arterial
annula into the ascending aorta, and the venous cannulae into
he superior and inferior vena cavae. The perfusion system,
onsisting of a roller pump and membrane oxygenator (Sen-
oika Corp, Tokyo, Japan), was primed with lactated Ringer
olution. A second dose of heparin (150 U/kg) was added before
he beginning of rewarming. Alpha-stat strategy was used for
lood pH management.
easurement of Somatosensory Evoked Potentials
ingle-channel recordings were obtained on a Nicolet Compact
our/CA 2000 (Nicolet JAPAN Corp, Tokyo, Japan). Three needle
lectrodes were positioned: the first over the head approximately 2
m dorsal to the coronal suture, the second in the upper right-hand
ide of the sternum, and the third (the reference electrode) on the
ight shoulder. The median nerve of the right forelimb was ex-
osed and stimulated with a bipolar stimulator. The pulse duration
sed was 100 msec, and the strength of the stimulating current was
to 5 mA with a frequency of 5.1 Hz. A total of 300 responses
ere obtained and averaged with automatic artifact rejection by
etting the filter between approximately 5 and 1000 Hz. The
entral conduction time (CCT), indicating the transmission time of
euronal activity in the brain, was measured as an interpeak
atency of N2 (the second negative wave) and N4 (the fourth
egative wave). The amplitude ratio between N4 and N1 (the first
egative wave), an indicator of neuronal activity in the sensory
ortex, was calculated. The preoperative and postoperative values
ere compared.
xperimental Protocol
wenty-four female mongrel dogs were divided into the following
groups: group A, intact, non-edaravone group (n  6); group B,
ntact, edaravone-treated group (n  6); group C, infarct, non-
daravone group (n  6); and group D, infarct, edaravone-treated
roup (n  6). Animals of all 4 groups underwent deep hypother-
ia with ASCP. CPB flow was maintained at approximately 50 to
0 mL/kg/min in accordance with the amount of venous return.
fter the animals were cooled to a rectal temperature of 20°C,
SCP was initiated at a flow rate of 10 mL/kg/min by clamping
he proximal ascending aorta, the left subclavian artery, and the
escending aorta. The lower half of the body was not perfused
and Cardiovascular Surgery ● Volume 133, Number 3 711
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CSPuring ASCP. After 120 minutes of ASCP, CPB was returned to its
riginal flow rate. Then, rewarming to a rectal temperature of 36°C
as performed. Differences between the rectal and arterial tem-
eratures were always kept within 5°C in both cooling and re-
arming phases.
rug Delivery Protocol
n the edaravone-treated groups, first, edaravone 1.5 mg/kg in 100
L normal saline solution was dripped into the extracorporeal
ircuit just before the beginning of cooling. Because it takes
pproximately 30 minutes to obtain a steady plasma level of
daravone after its intravenous injection, we made sure that the
rst dose of edaravone was completed 30 minutes before the
nitiation of ASCP.13 To ensure a stable plasma level of the drug
ntil the end of the experiment, a second dose of edaravone (1.5
g/kg) was added to the circuit in the same method 30 minutes
fter the first. For the non-edaravone group, only 100 mL of
ormal saline solution without edaravone was administered into
he circuit at the same time points.
rotocol for Blood Biochemistry
lood samples were obtained on the following 8 occasions: (1)
efore the operation; (2) 5 minutes after the initiation of CPB; (3)
n reaching a rectal temperature of 28°C in the cooling phase; (4)
n reaching a rectal temperature of 20°C in the cooling phase;
5) 60 minutes after the initiation of ASCP; (6) at the end of ASCP;
7) on reaching a rectal temperature of 28°C in the rewarming phase;
nd (8) on reaching a rectal temperature of 36°C in the rewarming
hase. Sampled blood was centrifuged, and protein was extracted
rom the serum. Malondialdehyde (MDA), a marker of free radical
roduction and lipid peroxidation of membrane polyunsaturated
atty acid, was measured by means of thiobarbituric acid fluores-
ence (FP-777; Nihon Bunko, Tokyo, Japan).14,15 Hexanoyl-lysine
HEL) formed by the reaction between linoleic acid hydroperoxide
nd lysine is another biomarker of oxidative stress, which was
easured by the enzyme-linked immunosorbent assay method
sing the HEL adduct enzyme-linked immunosorbent assay kit
Japan Institute for the Control of Aging, Shizuoka, Japan).16,17
erum glutamate, a biomarker of neural cell damage, was mea-
ured on a column packed with reverse-phase support with a
pecial device (PICO-TAG; Waters Corp, Milford, Mass). Blood
actate was measured using a blood gas analyzer (Stat Profile Ultra
; Nova Biomedical Corp, Tokyo, Japan), and the venous-arterial
actate difference (VALD) was calculated.
tatistical Analysis
ll values are expressed as means  standard error. One-way
nalysis of variance was used for comparison among the groups.
hen the 1-way analysis of variance showed a significant differ-
nce (P  .05), we compared the 2 groups by using the Tukey
onestly significant difference test.
esults
mportant preoperative and intraoperative data are shown in
able 1. There were no significant differences in the pre-
perative physiologic variables and the intraoperative data
mong the groups. w
12 The Journal of Thoracic and Cardiovascular Surgery ● Marclood Biochemistry
he preoperative biochemical parameters did not show any
ignificant differences among the groups. Serum concentra-
ion of MDA in group C was significantly higher than that
n the intact groups (groups A and B) at the end of ASCP
P  .012). In addition, the level was significantly higher in
omparison with that in groups A and B, as well as that in
roup D in the rewarming phase (P  .047 at 28°C; P 
003 at 36°C) (Figure 1). In group C, the serum concentra-
ion of HEL became significantly higher compared with that
n groups A and B, and group D at the end of ASCP, with
he differences continuing to widen until the end of the
xperiment (P  .005 at the end of ASCP; P  .0013 at
8°C; P  .0001 at 36°C) (Figure 2). Serum concentrations
f glutamate in group C were significantly higher in com-
arison with groups A and B, and group D during the
ewarming phase (P  .001 at 28°C, P  .0006 at 36°C)
Figure 3). In group C, VALD was significantly greater than
hat in the intact groups at 28°C in the rewarming phase
P  .0082), although the difference was not significant
hen compared with group D (Figure 4). However, the 2
ntact groups did not differ significantly with regard to the
bove parameters. Likewise, values in group D were not
ignificantly different when compared with those in the
ntact groups.
omatosensory Evoked Potentials
he preoperative CCT and N4/N1 amplitude ratio did not
how any difference among the groups. In group C, the
ostoperative CCT was significantly prolonged compared
ith that in the intact groups (A and B) and group D (group
, 109%  3.6%; group B, 98.7%  4.1%; group C,
95.6%  25.7%; group D, 142.3%  5.4%; P  .0002)
Figure 5). Moreover, in group C, the postoperative N4/N1
mplitude ratio decreased significantly compared with that
n the intact groups and group D (group A, 90.2%  7.1%;
roup B, 101%  7.1%; group C, 30.8%  8.1%; group D,
0.9% 5.3%; P .0001). No significant differences were
oted between the 2 intact groups with regard to the post-
perative CCT and N4/N1 amplitude ratio. Values in group
were also not significantly different compared with those
n the intact groups.
iscussion
n brains with old infarction, ischemia can occur in the
eri-infarct area, where the baseline blood flow is low. Such
egions are known as chronic penumbra, which are nour-
shed by collateral blood flow.18 In the present study, we
aintained a cerebral perfusion flow of 10 mL/kg per
inute (perfusion pressure 40–50 mm Hg) during ASCP,
hich is consistent with our clinical practice. This perfusion
ow is adequate for normal brains because they have a
ider safety margin for cerebral ischemia.19 However, the
h 2007
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Pow may not be adequate for the chronic penumbra region.
ing and colleagues20 reported an accelerated free radical
roduction in the peri-infarct region after transient focal
schemia in mice brain. Thus, it seems that brain ischemia
ABLE 1. Preoperative and intraoperative data
Intact group
Group A Group B
(non-edaravone) (edaravone-tre
ge (mo) 13.3 0.7 13.7 1.
ody weight (kg) 13.8 0.7 13.1 0.
uration after CI (mo) — —
reoperative Ht (%) 35.5 1.3 33.8 1.
AP (mm Hg)
Preoperative 135.3 9.3 127.5 3.
On CPB 76.2 4.7 74.5 3.
Cooling 28°C 66.5 3.9 65.2 3.
Cooling 20°C 59.5 2.7 56.5 2.
ASCP 60 min 43.5 2.3 42.3 2.
End of ASCP 49.0 5.1 46.0 3.
Rewarming 28°C 75.3 6.0 74.8 5.
Rewarming 36°C 78.2 3.8 73.3 2.
aO2 (mm Hg)
Preoperative 106.5 7.5 104.1 7.
On CPB 272.3 72.4 161.9 20
Cooling 28°C 347.4 64.1 396.9 53
Cooling 20°C 735.2 31.2 655.6 21
ASCP 60 min 683.1 61.9 754.7 60
End of ASCP 729.7 32.7 766.7 7.
Rewarming 28°C 446.8 41.1 454.8 72
Rewarming 36°C 200.1 53.2 151.3 22
aCO2 (mm Hg)
Preoperative 29.2 3.6 33.1 6.
On CPB 30.5 2.7 32.4 1.
Cooling 28°C 37.2 5.2 41.5 1.
Cooling 20°C 35.7 5.3 41.5 2.
ASCP 60 min 26.5 2.1 30.9 2.
End of ASCP 27.1 1.5 31.9 0.
Rewarming 28°C 31.2 3.9 28.1 0.
Rewarming 36°C 30.8 4.2 30.5 0.
rterial pH
Preoperative 7.44 0.02 7.43 0.
On CPB 7.38 0.03 7.37 0.
Cooling 28°C 7.35 0.03 7.36 0.
Cooling 20°C 7.37 0.03 7.37 0.
ASCP 60 min 7.37 0.02 7.36 0.
End of ASCP 7.36 0.02 7.37 0.
Rewarming 28°C 7.36 0.02 7.34 0.
Rewarming 36°C 7.37 0.02 7.33 0.
ime required (min)
Cooling 58.2 3.5 54.8 3.
Rewarming 75.6 5.3 72.8 3.
I, Cerebral infarction; Ht, hematocrit;MAP, mean artery pressure; CPB, ca
nalysis of variance.nd the consequent free radical production in the chronic c
The Journal of Thoracicenumbra region cause neurologic dysfunction after ASCP
or brain with old infarction.
It is thought that hypothermic ASCP itself can also give
ise to cerebral ischemia, particularly in a setting of old
Infarct group
Group C Group D
(non-edaravone) (edaravone-treated) P value*
15.2 0.6 15.8 0.5 .06
13.9 0.8 13.6 1.7 .90
3.5 0.4 4.0 0.3 .26
36.5 1.9 34.3 1.3 .57
134.3 3.6 129.5 8.5 .82
77.2 4.2 75.8 2.4 .97
66.8 4.3 62.3 4.5 .86
60.2 2.8 59.7 4.0 .84
43.0 4.6 44.2 3.3 .98
45.8 3.8 43.2 2.8 .77
75.0 6.7 69.5 3.2 .85
74.8 5.7 72.2 4.6 .78
115.8 36.2 103.5 11.8 .84
214.6 50.4 248.3 66.2 .55
469.1 61.4 467.0 49.6 .39
562.9 77.5 679.7 66.7 .19
792.2 32.8 797.1 25.4 .33
688.0 28.7 718.3 40.5 .34
498.6 23.4 466.5 21.5 .85
203.8 73.9 145.4 28.7 .75
26.8 4.9 36.0 8.2 .72
35.8 1.3 29.4 1.4 .10
37.3 1.4 36.4 1.7 .61
36.5 0.9 36.7 1.6 .46
34.0 0.8 31.3 2.9 .13
32.0 1.5 29.1 2.5 .14
28.8 2.9 27.0 0.7 .67
29.0 2.4 27.8 2.2 .85
7.46 0.02 7.42 0.01 .48
7.39 0.03 7.37 0.02 .87
7.34 0.04 7.34 0.02 .95
7.35 0.04 7.34 0.01 .91
7.35 0.03 7.35 0.02 .90
7.36 0.03 7.37 0.02 .98
7.34 0.03 7.36 0.02 .95
7.35 0.02 7.36 0.03 .88
56.7 2.1 58.6 4.0 .86
72.7 3.8 75.7 5.7 .94
lmonary bypass; ASCP, antegrade selective cerebral perfusion. *One-wayated)
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CSPhe loss of cerebral autoregulation,21 which may result in
erebral vasoconstriction. This, in turn, may lead to a global
eduction in cerebral blood flow. Moreover, phenomena
uch as low flow-induced astrocyte edema22 and cerebral
asospasm may also contribute to a further reduction in
erebral blood flow, particularly at the penumbral region.
Brain ischemia initiates a complex cascade of metabolic
vents, several of which involve the generation of nitrogen
nd oxygen free radicals. These free radicals and related
eactive chemical species mediate much of the damage that
ccurs after transient brain ischemia and in the penumbral
egion of infarcts caused by permanent ischemia.23 Free
igure 1. Changes in serum MDA concentration. Values at differ-
nt time points are expressed as percentages of the preoperative
alue (see text). In group C, values significantly increased at time
oints 6 to 8 (*group C vs groups A and B, P < .05; **group C vs
roups A, B, and D, P < .05). MDA, Malondialdehyde.
igure 2. Changes in serum HEL concentration. Values at differ-
nt time points are expressed as percentages of the preoperative
alue (see text). In group C, values significantly increased com-
ared with that in all other groups at points 6 to 8 (*group C vs
roups A, B, and D, P < .001). HEL, Hexanoyl-lysine. e
14 The Journal of Thoracic and Cardiovascular Surgery ● Marcadical species lead to oxidation of lipids, protein, and
ucleic acid, which might alter cellular function in a
ritical way, resulting in neurologic injury and subse-
uent neurologic dysfunction.24,25 Aldehydes, such as
DA and 4-hydroxy-2-nonenal, have been well-known
roducts of lipid peroxidation.14,26 HEL is a novel lipid
ydroperoxide-modified lysine residue formed in the ear-
ier stage of lipid peroxidation by oxidative modification
f linoleic acid or arachidonic acid.16,17 To our knowl-
dge, it has not been previously used as a marker of free
adical production in a cerebral infarction model. Be-
igure 3. Changes in serum glutamate concentration. Values at
ifferent time points are expressed as percentages of the preop-
rative value (see text). In group C, values significantly increased
ompared with that in all other groups during the rewarming
hase (*group C vs groups A, B, and D, P < .001).
igure 4. Level of VALD. Values are shown at different time points
see text). In group C, VALD was significantly greater than that in
he intact groups at 28°C in the rewarming phase (*group C vs
roups A and B, P < .001). VALD, Venous-arterial lactate differ-
nce.
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Pause brain is a fat-rich tissue, we believe that HEL can
e a reliable biochemical marker of free radical produc-
ion induced by ischemic brain injury.
In the present study, the animals in group C (the cerebral
nfarct group) showed a remarkable increase in serum HEL
nd MDA at the end of ASCP. These findings suggested that
SCP induced ischemia in brains with old cerebral infarc-
ion, which resulted in accelerated free radical production.
oreover, in group C, we observed a prolongation of CCT
nd a decrease in the N4/N1 amplitude ratio, whereas none
f these changes were seen in the intact animals. Previous
tudies demonstrated that impaired somatosensory evoked
otential was associated with cerebral injury in permanent
schemic models.27,28 Our findings were consistent with the
bove findings in the sense that we also found brains with
ld infarction showing functional impairment with acceler-
tion of free radical production caused by ischemia during
SCP, whereas the intact brain showed no such evidence of
schemic damage.
The animals in group D (the edaravone-treated infarct
roup) showed a reduction in the level of serum MDA
nd HEL concentrations compared with those in the
on-edaravone–treated infarct animals. A decrease in post-
perative CCT prolongation and the recovery of postoper-
tive N4/N1 amplitude ratio were also noted in group D,
uggesting that free radical scavenging was effective in
educing neurologic dysfunction after ASCP in brains
ith old infarction. Although the cerebral protective ef-
ect of edaravone in acute cerebral ischemia is well
igure 5. Changes in CCT and N4/N1 amplitude ratio. Values are
xpressed as percentages of the preoperative values (see text). In
roup C, postoperative CCT was significantly prolonged com-
ared with that in all other groups. The postoperative N4/N1
mplitude ratio in group C decreased significantly compared with
hat in all other groups (*group C vs groups A, B, and D, P <
0001). CCT, Central conduction time.escribed,9,10,22 to our knowledge, this is the first report
The Journal of Thoracicemonstrating the neuroprotective effect of edaravone dur-
ng CPB for permanent cerebral infarction.
In our study, increasing free radical production was
ound from the point of ASCP termination until the end of
he experiment in group C. Serum glutamate also showed a
arallel increase during the rewarming phase in this group.
n the rewarming phase, VALD also became greater in
roup C, perhaps indicating an acceleration of anaerobic
lycolysis in the brain tissue.29 These findings may be
xplained by neural cell damage being worsened by accel-
rated free radical production and increased cellular metab-
lism. It is important to note that the serum concentration of
lutamate decreased in the edaravone-treated infarct group
group D) in this study. This suggests that edaravone atten-
ated ischemic and free radical–mediated neural cell dam-
ge and by doing so, reduced neurologic dysfunction that
as documented by the results of somatosensory evoked
otential examination in group D. From the above results, it
s evident that in brains with old infarction, free radical
cavenging provides an effective way to attenuate functional
nd metabolic damage to neural cells within the chronic pen-
mbra region in the rewarming phase after ASCP.
However, the present study has a number of important
imitations. Although it can be assumed from the biochem-
cal assessment performed in the present study that brain
schemia causes free radical production in the chronic pen-
mbra region, the actual regional cerebral blood flow during
SCP was not measured. Thus, the relationship between
schemia and free radical–mediated neurologic injury is not
irectly evident. Transcranial Doppler sonography or near-
nfrared spectroscopy may be used to measure regional
erebral blood flow.30 Moreover, we could not perform
rain histopathology to document ischemia-induced tissue
amage in a graded manner.
onclusions
e examined the influences of prophylactic administration
f edaravone, a free radical scavenger, on brains with or
ithout old cerebral infarction in dogs undergoing ASCP.
erebral ischemia occurred during experimental ASCP re-
ulting in postoperative neurologic dysfunction, which was
ttenuated by prophylactic administration of edaravone. It is
herefore expected that prophylactic administration of
daravone could be useful for brain protection in ASCP for
igh-risk patients with a history of cerebral infarction.
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